Surging commercial development of antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), and mRNA therapies is fueling unprecedented growth across the global Oligonucleotide Api Market. Active pharmaceutical ingredient (API) manufacturers utilize high-throughput solid-phase synthesis platforms to produce custom phosphodiester and phosphorothioate oligonucleotide sequences. Chemical...